ConductScience.org, home

Paper8095569

Detection of rifampicin-resistance mutations in Mycobacterium tuberculosis.

Telenti A and 8 others. Lancet, 1993. Cited by 1,012 papers, by iCite.

Cite this record

ConductScience Library. Detection of rifampicin-resistance mutations in Mycobacterium tuberculosis. Papers, record 8095569. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/8095569

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Detection of rifampicin-resistance mutations in Mycobacterium tuberculosis.
PubMed
Journal
Lancet
PubMed
Year
1993
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
1,012
iCite
Relative citation ratio, by iCite
31.8
iCite
Revised in PubMed
2025-10-30
PubMed

Authors9

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Telenti AA
2Imboden PP
3Marchesi FF
4Lowrie DD
5Cole SS
6Colston MJM J
7Matter LL
8Schopfer KK
9Bodmer TT

Source PubMed

Download CSV of authors

Topics8

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
MutationMajor topic
Mycobacterium tuberculosisMajor topic
RifampinMajor topic
Base Sequence
DNA-Directed RNA Polymerases
Drug Resistance, Microbial
Molecular Sequence Data
Polymerase Chain Reaction

Source PubMed

Download CSV of topics

Comments and corrections1

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

KindPMIDTitleIn Papers
Comment in8095575Detecting multidrug resistant tuberculosis early.https://conductscience.org/library/papers/8095575

Source PubMed

Download CSV of comments and corrections

Cited by469

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1,012 citations.

PMIDTitleJournalYearIn PapersSource
42941774Targeted Nanopore Sequencing for Molecular Characterization of First-Line Drug Resistance and Treatment Outcomes Among Patients in the Republic of Congo.Int J Mol Sci2026https://conductscience.org/library/papers/42941774PubMed
42823951From mutation detection to treatment decisions: CRISPR-enabled diagnostics for drug-resistant tuberculosis.Front Bioeng Biotechnol2026https://conductscience.org/library/papers/42823951PubMed
42725002Burden of Rifampicin Resistance Among Patients With Tuberculosis at a Tertiary Care Center in Uttarakhand, India: A Prospective Cross-Sectional Study.Cureus2026https://conductscience.org/library/papers/42725002PubMed
42603138Analytical performance of a multi-target open real-time PCR assay for simultaneous detection of tuberculosis, non-tuberculous mycobacteria, and drug resistance in a high-burden setting.Microbiol Spectr2026https://conductscience.org/library/papers/42603138PubMed
42536082High-precision binary trait association on phylogenetic trees.Microb Genom2026https://conductscience.org/library/papers/42536082PubMed
42430119Prevalence of extensively drug-resistant tuberculosis and drug resistance patterns in Asia and Africa (2000-2025): systematic review and meta-analysis.Infection2026https://conductscience.org/library/papers/42430119PubMed
41736370Proteostasis-targeted antibacterial strategies.J Microbiol2026https://conductscience.org/library/papers/41736370PubMed
41718507Pattern and prevalence of rifampicin and isoniazid-resistant tuberculosis using genotype MTBDRplus assay in Ethiopia.Microbiol Spectr2026https://conductscience.org/library/papers/41718507PubMed
41322936Strategies and Recent Advances in Tackling Antibacterial Resistance in India: A Comprehensive Narrative Review.Cureus2025https://conductscience.org/library/papers/41322936PubMed
41217574Characteristics of Clostridium perfringens from sheep (Ovis aries) flocks in Northern China.Vet Res Commun2025https://conductscience.org/library/papers/41217574PubMed
41207943Key Proteins and Enzymatic Mechanisms Underlying Drug Resistance in Mycobacterium tuberculosis.Adv Exp Med Biol2026https://conductscience.org/library/papers/41207943PubMed
41127414Epidemiological Profile and rpoB Gene Mutations in Pulmonary Tuberculosis Patients From Sulaymaniyah, Iraq: Evidence of Novel Genetic Variations and Beijing Lineage Emergence.Int J Microbiol2025https://conductscience.org/library/papers/41127414PubMed
41084085Genomic characterisation of recurrent Mycobacterium avium isolates from chronically infected patients reveals patterns of within-host evolution.Genome Med2025https://conductscience.org/library/papers/41084085PubMed
40979939Genetic Analysis of Molecular Mechanisms of Drug Resistance in Mycobacterium tuberculosis Against Four Major First-Line Anti-Tuberculosis Drugs (Isoniazid, Rifampin, Ethambutol, and Pyrazinamide).Infect Drug Resist2025https://conductscience.org/library/papers/40979939PubMed
40964422Prevalence of pulmonary tuberculosis and its associated risk factors among suspected patients visiting Durbete Primary Hospital, northwest Ethiopia: A cross-sectional study.J Public Health Res2025https://conductscience.org/library/papers/40964422PubMed
40887591Efflux pumps positively contribute to rifampin resistance in rpoB mutant Mycobacterium tuberculosis.Ann Clin Microbiol Antimicrob2025https://conductscience.org/library/papers/40887591PubMed
40757508Low-complexity automated nucleic acid amplification tests for extrapulmonary tuberculosis and rifampicin resistance in adults and adolescents.Cochrane Database Syst Rev2025https://conductscience.org/library/papers/40757508PubMed
40728034Xpert MTB/RIF Ultra assay for pulmonary tuberculosis and rifampicin resistance in adults and adolescents.Cochrane Database Syst Rev2025https://conductscience.org/library/papers/40728034PubMed
40671870Dinucleotide codon substitutions as a signature of diversifying selection in Mycobacterium tuberculosis.Front Mol Biosci2025https://conductscience.org/library/papers/40671870PubMed
40574359Discovery of Putative GyrB Inhibitors against Mycobacterium tuberculosis: A Combined Virtual Screening and Experimental Study.Curr Med Chem2026https://conductscience.org/library/papers/40574359PubMed

See all 469 cited byDownload CSV of cited by

Data2

The data bank entries PubMed's record names. Trial numbers are under Trials.

Data bankAccessionSource
GENBANKL05910GENBANK
GENBANKV00340GENBANK

Download CSV of data

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • References
  • Genes
  • Drugs

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/8095569

GET https://conductscience.org/api/papers/v1/8095569/cited_by?page=2